Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01004_DB01048_nanopub.RAnQMlldec0H96RKu_h1z9HPQEZ6dbm3ZPivmJ6zuryAg#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01004_DB01048 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01004_DB01048 label "DDI between Ganciclovir and Abacavir - The adverse/toxic effects of reverse transcriptase inhibitors (nucleoside), such as Abacavir, may be enhanced by Ganciclovir. There is a risk of hematologic toxicity. Diligent monitoring during concomitant therapy is required. [drugbank_resource:DB01004_DB01048]" assertion.
- drugbank_resource:DB01004_DB01048 identifier "drugbank_resource:DB01004_DB01048" assertion.
- drugbank_resource:DB01004_DB01048 title "DDI between Ganciclovir and Abacavir - The adverse/toxic effects of reverse transcriptase inhibitors (nucleoside), such as Abacavir, may be enhanced by Ganciclovir. There is a risk of hematologic toxicity. Diligent monitoring during concomitant therapy is required." assertion.
- drugbank:DB01048 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01004_DB01048 assertion.
- drugbank:DB01004 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01004_DB01048 assertion.